Recent approaches to mRNA vaccine delivery by lipid-based vectors prepared by continuous-flow microfluidic devices - Supporting Informations

Figure S1. Schematic representation of amino lipids’ formulations for mRNA-LNPs, including cationic/ionizable lipid, helper lipids, cholesterol, phospholipids, and poly (ethylene glycol) (PEG)

Figure S2. Microfluidic-assisted fabrication of LNPs (micromixer principle)

Figure S3. mRNA vaccine engineering by hybridization of mRNA with PEG-OligoRNAs